David McCormick tours AI-powered biotech labs at Penn

Source Domain: whyy.org

U.S. Senator Dave McCormick visited the University of Pennsylvania’s AIRFoundry lab to highlight the potential of artificial intelligence (AI) in accelerating biomedical and drug development.
The AIRFoundry lab, funded by the National Science Foundation, utilizes AI, robotics, and automation to expedite the creation of RNA-based medicines and biotechnology applications.
AI is facilitating faster research by enabling scientists to process vast data sets, predict successful drug formulations, and automate key parts of the drug discovery process, turning years of work into weeks.
The potential applications of AI-driven research extend beyond medicine to fields like agriculture and veterinary science, with the goal of significantly reducing the time and cost of drug development.
The visit highlighted the commercialization opportunities birthed from Penn’s research, such as InfiniFluidics, a company that has developed an AI-powered system to accelerate RNA-based drug treatment creation.
Penn is noted for its interdisciplinary approach to AI, highlighted by its unique undergraduate degree program in AI that emphasizes applications in health and robotics.
The AI program aims to expand to 250 students next year, reflecting the growing importance and career opportunities in AI.

You may have missed